Purchases and Sales Made in Q3 2022 in C4 Therapeutics, Inc. (CCCC)
This table provides information about the institutional ownership of C4 Therapeutics, Inc. (CCCC) during Q3 2022. The information is specifically focused on institutions that hold shares of C4 Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-204K- 64.8% |
$1.64M - $2.6M
|
111K
$470K
|
|
|
Nov 14, 2022
Q3 2022
|
Rtw Investments, LP
New York, NY |
SELL
|
- |
-275K- 8.9% |
$2.21M - $3.52M
|
2.82M
$12M
|
|
|
Nov 14, 2022
Q3 2022
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
SELL
|
- |
-750K- 12.84% |
$6.03M - $9.58M
|
5.09M
$21.6M
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.42M- 32.38% |
$11.4M - $18.1M
|
2.96M
$12.6M
|